Intelligence Profile
Research Papers
Currently, there is limited information available on the compound "PIEZO-101" as no relevant papers have been retrieved from PubMed. However, there is a clinical trial registered under the ID NCT07671027. This is an early-phase (Phase 1) study, designed as a first-in-human trial to evaluate the safety and gather preliminary proof-of-concept data for PIEZO-101. As the trial is in the "not yet recruiting" stage, no results or participant details are available at this time. Further updates will require the initiation of this trial.
Disclaimer: This information is for educational purposes only and not intended as medical advice. For personal health concerns, consult a healthcare professional.